Valuation : Strides Pharma Science Limited

Market Cap 9.4TCr 98Cr 85Cr 79Cr 73Cr 136.66Cr 137.09Cr 942.83Cr 367.86Cr 4.75TCr 369.29Cr 361.26Cr 16TCr P/E 2027 *
15x
P/E 2028 * 10.7x
Enterprise Value 9.4TCr 98Cr 85Cr 79Cr 73Cr 136.66Cr 137.09Cr 942.83Cr 367.86Cr 4.75TCr 369.29Cr 361.26Cr 16TCr EV / Sales 2027 *
1.61x
EV / Sales 2028 * 1.36x
Free-Float
68.12%
Yield 2027 *
0.29%
Yield 2028 * 0.29%
1 day+1.10%
1 week+3.77%
Current month+0.60%
1 month+0.60%
3 months-5.76%
6 months+23.80%
Current year+14.52%
1 week 976
Extreme 976
1,038.1
1 month 931.3
Extreme 931.3
1,056
Current year 768.65
Extreme 768.65
1,231
1 year 768.65
Extreme 768.65
1,231
3 years 433.7
Extreme 433.7
1,675
5 years 263.35
Extreme 263.35
1,675
10 years 263.35
Extreme 263.35
1,675
Manager TitleAgeSince
Chief Executive Officer - 01/06/2024
Director of Finance/CFO 42 01/06/2024
Chief Tech/Sci/R&D Officer - 21/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member - 18/05/2017
Director/Board Member 82 18/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.20%+3.77%+14.99%+132.52% 98Cr
+0.28%+0.78%+23.13%+73.16% 4.82TCr
+0.66%+0.33%+54.40%+120.88% 4TCr
-2.13%+5.61%+17.62%+86.26% 1.24TCr
-0.55%-1.53%-10.79%+12.59% 1.2TCr
+0.19%0.00%+29.35%+150.00% 934.62Cr
-1.05%-0.75%+26.36%+49.92% 775.13Cr
-1.16%+4.06%+29.11%+224.41% 742.6Cr
-0.26%+0.27%+43.89%-11.26% 721.72Cr
-0.53%-1.53%-36.09%+17.02% 530.08Cr
Average -0.34%+2.43%+19.20%+85.55% 1.51TCr
Weighted average by Cap. -0.08%+1.43%+27.97%+87.46%

Financials

2027 *2028 *
Net sales 5.82TCr 61Cr 53Cr 49Cr 45Cr 85Cr 85Cr 584.01Cr 227.86Cr 2.94TCr 228.75Cr 223.77Cr 9.75TCr 6.91TCr 72Cr 62Cr 58Cr 53Cr 100.49Cr 100.81Cr 693.26Cr 270.48Cr 3.49TCr 271.54Cr 265.63Cr 12TCr
Net income 627.73Cr 6.57Cr 5.66Cr 5.31Cr 4.84Cr 9.13Cr 9.15Cr 63Cr 25Cr 316.88Cr 25Cr 24Cr 1.05TCr 879.8Cr 9.21Cr 7.93Cr 7.44Cr 6.79Cr 13Cr 13Cr 88Cr 34Cr 444.12Cr 35Cr 34Cr 1.47TCr
Net Debt - -
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,535
Date Price Change Volume
31/26/31 1,032.10 +1.20% 2,47,955
28/26/28 ₹1,019.90 +3.75% 4,35,651
27/26/27 ₹983.00 +0.01% 94,124
26/26/26 ₹982.90 -0.38% 97,630
25/26/25 ₹986.60 -0.70% 2,09,006
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,019.90INR
Average target price
1,338.67INR
Spread / Average Target
+31.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STAR Stock